Results 101 to 110 of about 31,724,613 (234)

Pulmonary vascular disease in a child with atrial septal defect of the secundum type and type I glycogen storage disease.

, 1996
A rare combination of atrial septal defect of the secundum type and type I glycogen storage disease was seen with early fatal outcome due to rapidly progressive severe pulmonary vascular disease.
Zimmermann A, Bolz D, Stocker F
core   +1 more source

Multi‐Target Pharmacological Mechanisms of Salvia miltiorrhiza Bunge in Metabolic Syndrome and Cardiovascular Diseases: A Comprehensive Review Based on the Theory of “Same Treatment for Different Diseases”

Phytotherapy Research, EarlyView.
Salvia miltiorrhiza Bunge in metabolic syndrome and cardiovascular diseases: multi‐target actions on shared signaling pathways. ABSTRACT Metabolic syndrome (MetS) represents a clinical disorder characterized by the clustering of conditions including obesity, elevated blood sugar levels, and high lipid levels, which are intricately linked to the onset ...
Zhiyi Jia, Kaiyi Wu, Jiaying Qi, Nana Huang, Yusheng Liu, Xiumei Gao, Rong Sun   +6 more
wiley   +1 more source

Natural Products Exhibit Therapeutic Potential in Treating Rheumatoid Arthritis by Targeting the PI3K/Akt Signaling Pathway

Phytotherapy Research, EarlyView.
This review summarizes how natural products, mainly including flavonoids, terpenoids, alkaloids, and polyphenols alleviate RA via PI3K/Akt pathway, regulating inflammation, proliferation, apoptosis, angiogenesis, and osteoclast differentiation. The figure was created by Figdraw (https://www.figdraw.com/#/).
Haishuo Ren, Yige Wang, Wenjing Ma, Omachi Daniel Ogaji, Shujing Chen, Kunze Du, Xuemi Zhang, Bo Xu, Shanxing Zhai, Shiming Fang, Yanxu Chang   +10 more
wiley   +1 more source

Rotenone Induces Morphological Damage and Reduction in Catecholamine Levels in the Central Nervous System of the Ascidian Styela plicata

Environmental Toxicology, EarlyView.
ABSTRACT Ascidians are invertebrates that occupy a key phylogenetic position as a sister group of the vertebrates. The organization of their central nervous system (CNS), with cortex and medulla, indicates a plesiomorphic character of the gray and white matter of vertebrates, making this group of animals useful for studies of neurodegenerative events ...
Andressa de Abreu Mello, Carlos Augusto Borges de Andrade Gomes, Rafaela Rocha dos Santos, Cintia Monteiro de Barros, Silvana Allodi   +4 more
wiley   +1 more source

"Bull's eye" appearance of hepatocellular adenomas in patients with glycogen storage disease type I - atypical magnetic resonance imaging findings: Two case reports. [PDF]

World J Clin Cases, 2021
Vernuccio F, Austin S, Meyer M, Guy CD, Kishnani PS, Marin D.   +5 more
europepmc   +1 more source

Delayed Diagnosis of Glycogen Storage Disease Type III

, 2012
A case of a delayed diagnosis in adult age of a glycogen storage disease type III is ...
Flavio Faletra, Cont, Gabriele, Paolo Gasparini, MAGGIORE, Giuseppe, Martelossi, Stefano, Cunto, Angela De, Gasparini, Paolo, Angela De Cunto, Denise Cassandrini, Minen, Federico, Cassandrini, Denise, Federico Minen, Faletra, Flavio, Alessandro Ventura, Stefano Martelossi, Giuseppe Maggiore, Ventura, Alessandro, Gabriele Cont   +17 more
core   +1 more source

Incidence and Risk Factors of Late‐Onset Hypoglycemia in Extremely Low Gestational Age or Extremely Low Birth Weight Infants

Acta Paediatrica, EarlyView.
ABSTRACT Aim To determine incidence and risk factors associated with late‐onset hypoglycemia in extremely preterm or extremely low birth weight infants. Methods Retrospective single‐center cohort study including infants with a gestational age < 28 weeks or birth weight < 1000 g.
Lara Canova, Roland P. Neumann, Sven M. Schulzke   +2 more
wiley   +1 more source

Type I glycogen storage disease:Straight to the point of care

Type I glycogen storage disease is a disorder of glucose-6-phosphate breakdown, associated with impaired glycogenolysis and gluconeogenesis. It typically presents in infancy with hypoglycaemia, hyperlacticacidaemia, hypertriglyceridaemia, and ...
Schreuder, Andrea B., de Boer, Foekje, Derks, Terry G.J.; id_orcid   +2 more
core   +3 more sources

Global Landscape of SLC37A4 Variants and Their Potential Amenability to Pharmacological Chaperone Therapy in Glycogen Storage Disease Type Ib

Sci
Glycogen storage disease Ib (GSD Ib) is an ultra-rare metabolic disease caused by variants in the SLC37A4 gene affecting activity of the glucose-6-phosphate transporter (G6PT).
Anita Skakic, Kristel Klaassen, Marina Andjelkovic, Jovana Komazec, Marina Parezanovic, Nikola Jocic, Maja Djordjevic Milosevic, Maja Stojiljkovic   +7 more
doaj   +1 more source

[Advances on the management of renal lesion in glycogen storage disease type I]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2021
Wu WC, Wang JS.
europepmc   +1 more source